How Genetic Testing Company Tempus AI Is Using Data and Artificial Intelligence to Help Personalize Cancer Care ...

Tempus AI and BioNTech have entered a multiyear collaboration to put Tempus' data to work on the immunotherapy company's oncology pipeline. The collaboration involves Chicago-based Tempus providing ...

Tempus AI (NASDAQ: TEM) is an emerging AI player in the healthcare field with a robust outlook for long-term growth and profitability. The company uses AI to manage patient testing and help physicians ...

JP Morgan analyst Rachel Vatnsdal reiterated the Neutral rating on Tempus AI, Inc. (NASDAQ:TEM) on Wednesday, with a price forecast of $55. On Tuesday, Tempus AI reported first-quarter revenue of $255 ...

CHICAGO--(BUSINESS WIRE)-- Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced publication of its study, ...

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced its participation in almost ...

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced a new strategic collaboration ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced the acceptance of 31 abstracts—including one oral presentation—for the ...

CHICAGO--(BUSINESS WIRE)-- Tempus AI, Inc. (TEM), a technology company leading the adoption of AI to advance precision medicine, today announced a multi-year collaboration with Whitehawk Therapeutics, ...

Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. After several years of speculation Tempus would go public, ...

Artificial intelligence (AI) is far from losing its luster with investors judging from two market-shaping events this week: Nvidia (NVDA) continues to hover around $3 trillion in market capitalization ...

CHICAGO--(BUSINESS WIRE)-- Tempus, a leader in artificial intelligence and precision medicine, today announced a multi-year, strategic research collaboration with Bristol Myers Squibb (NYSE: BMY). The ...